文献速递临床微生物分子诊断质量管理与危急值

脆弱拟杆菌感染的临床结局与分子特征

Clinical Outcomes and Molecular Characteristics of Bacteroides fragilis Infections.
PubMed 文献 · Ann Lab Med · 2024-10-31

发现多种ST型,ST157株cfiA上游IS1187与高水平碳青霉烯耐药相关,bft基因检出率30%,30天内死亡5例(14.7%),其中2例(5.9%)直接归因于脆弱拟杆菌感染。

要点

  • 脆弱拟杆菌感染30天内死亡14.7%,其中5.9%直接归因于该菌感染。
  • ST157分离株cfiA上游IS1187与高水平碳青霉烯耐药相关。
  • bft毒素基因在30%的分离株中检出。

核心结论

  • 脆弱拟杆菌感染可出现高水平碳青霉烯耐药ST157株,临床需警惕。

主要发现

  • 鉴定出多种多位点序列型,包括ST149(N=4)、ST11(N=4)、ST1(N=3)、ST21(N=2)、ST157(N=1)。
  • ST157分离株cfiA上游插入序列IS1187与高水平碳青霉烯耐药相关。
  • bft毒素基因在30%的分离株中检出。
  • 最常见合并症为糖尿病(26.5%)和非转移性癌症(23.5%)。
  • 5例患者(14.7%)在30天内死亡,其中2例(5.9%)死亡直接归因于脆弱拟杆菌感染。

关键数值与推荐

  • 无适当抗菌治疗时,脆弱拟杆菌群感染相关死亡率可高达50%。

临床怎么用

  • 临床遇脆弱拟杆菌感染时应警惕高水平碳青霉烯耐药ST157株的出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bacteroides fragilis is the most common opportunistic anaerobic pathogen. In the absence of appropriate antimicrobial therapy, mortality rates associated with B. fragilis group infections can reach as high as 50%. Therefore, we aimed to elucidate the clinical characteristics and outcomes of B. fragilis infections and the molecular genetic characteristics of B. fragilis isolates. Forty B. fragilis clinical isolates were collected at Hanyang University Hospital between January 2022 and December 2023. Antimicrobial susceptibility was tested using the agar dilution method. Whole-genome sequencing was conducted using the Illumina platform (Illumina, San Diego, CA, USA). Various multilocus sequence types of B. fragilis were identified, including ST149 (N=4), ST11 (N=4), ST1 (N=3), ST21 (N=2), and ST157 (N=1). The insertion sequence (IS) IS1187, located upstream of cfiA, was associated with high-level carbapenem resistance in the ST157 isolate. B. fragilis toxin genes (bft ) were identified in 30% of isolates. The most common comorbidities were diabetes mellitus (26.5%) and non-metastatic cancer (23.5%). Five patients (14.7%) died within 30 days, and two (5.9%) deaths were directly attributable to B. fragilis infection. The emergence of high-level MIC carbapenem-resistant B. fragilis ST157 has led to caution in the presence of B. fragilis infections.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Kim B, Kim M, Lee K, et al. Clinical Outcomes and Molecular Characteristics of Bacteroides fragilis Infections. Ann Lab Med. 2024. PMID: 39478317. doi:10.3343/alm.2024.0369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。